The Community Drug Early Warning System (CDEWS), funded by the Office of National Drug Control Policy (ONDCP), provides timely information about emerging drug use in criminal justice populations in local communities by collecting and re-testing urine specimens already obtained and tested for a limited panel of drugs by criminal justice testing programs. CDEWS or local staff sample specimens that are ready to be discarded and send them de-identified to an independent laboratory for testing for an expanded panel of drugs.
The DEA's Special Testing and Research Laboratory’s Emerging Trends Program compiled the data for this report to monitor new psychoactive substance (NPS) trends in the United States through queries of archived seizure and analysis information from drug evidence analyzed by the DEA laboratory system. This Fourth Quarter 2016 Report includes NPS seized and identified in the fourth quarter of CY2016. For opioids and analgesics, this report indicates that "Acryl fentanyl and P-Fluorobutyrylfentanyl were reported for the first time in the fourth quarter of 2016.
The U.S Department of Justice, Drug Enforcement Administration recently released the 2016 National Drug Threat Assessment Summary. The report features a variety of information regarding transnational criminial organizations, gangs, and drugs of abuse.
The University of Maryland Center for Advanced Study of Language (CASL) and the National Drug Early Warning System (NDEWS) Coordinating Center are working together to identify trends in drug use through Twitter.